Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Polton

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Veterinary Sciences|August 25, 2023
The Prognostic Role of Preoperative Hematological and Inflammatory Indices in Canine Appendicular OsteosarcomaKonstantinos Rigas, Jean-Benoit Tanis, Emanuela Morello, et al.
Veterinary and Comparative Oncology|September 30, 2021
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factorsJean-Benoit Tanis, Angharad B Simlett-Moss, Malgorzata Ossowksa, et al.
Veterinary and Comparative Oncology|June 29, 2019
Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary OncologyLaura Marconato, Carmit Chalfon, Riccardo Finotello, et al.
Veterinary and Comparative Oncology|July 27, 2018
Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumoursLaura Marconato, Gerry Polton, Damiano Stefanello, et al.
Veterinary and Comparative Oncology|May 13, 2020
Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology studyLaura Marconato, Silvia Sabattini, Julia Buchholz, et al.
Veterinary and Comparative Oncology|January 12, 2023
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomyEugenio Faroni, Silvia Sabattini, Dina Guerra, et al.
Plos One|August 15, 2014
Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphomaDammy Pinheiro, Yu-Mei Chang, Hannah Bryant, et al.
Veterinary and Comparative Oncology|January 14, 2020
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgeryLaura Marconato, Damiano Stefanello, Matti Kiupel, et al.
Frontiers in Veterinary Science|April 22, 2024
Melanoma of the dog and cat: consensus and guidelinesGerry Polton, Juan F Borrego, Francisco Clemente-Vicario, et al.
Veterinary and Comparative Oncology|March 12, 2023
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi-institutional retrospective studyCarmit Chalfon, Riccardo Finotello, Silvia Sabattini, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Veterinary Sciences|August 25, 2023
The Prognostic Role of Preoperative Hematological and Inflammatory Indices in Canine Appendicular OsteosarcomaKonstantinos Rigas, Jean-Benoit Tanis, Emanuela Morello, et al.
Veterinary and Comparative Oncology|September 30, 2021
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factorsJean-Benoit Tanis, Angharad B Simlett-Moss, Malgorzata Ossowksa, et al.
Veterinary and Comparative Oncology|June 29, 2019
Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary OncologyLaura Marconato, Carmit Chalfon, Riccardo Finotello, et al.
Veterinary and Comparative Oncology|July 27, 2018
Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumoursLaura Marconato, Gerry Polton, Damiano Stefanello, et al.
Veterinary and Comparative Oncology|May 13, 2020
Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology studyLaura Marconato, Silvia Sabattini, Julia Buchholz, et al.
Veterinary and Comparative Oncology|January 12, 2023
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomyEugenio Faroni, Silvia Sabattini, Dina Guerra, et al.
Plos One|August 15, 2014
Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphomaDammy Pinheiro, Yu-Mei Chang, Hannah Bryant, et al.
Veterinary and Comparative Oncology|January 14, 2020
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgeryLaura Marconato, Damiano Stefanello, Matti Kiupel, et al.
Frontiers in Veterinary Science|April 22, 2024
Melanoma of the dog and cat: consensus and guidelinesGerry Polton, Juan F Borrego, Francisco Clemente-Vicario, et al.
Veterinary and Comparative Oncology|March 12, 2023
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi-institutional retrospective studyCarmit Chalfon, Riccardo Finotello, Silvia Sabattini, et al.
Pageof 4